4Catalano C,Muscelli E,Quinones GA,et al.Effects of insulin on systemic and renal handing of albumin in nondiabetic and NIDDM subjects.Diabetes,1997,46(5):868～875. 被引量：1
5Liu ZH,Liu H,Peng A,et al.Amylin:a new component in the development of renal lesions in patients with type 2diabetes mellitus,J AM Soc Nephrol,2001,12(12):150. 被引量：1
6American Diabetes Association.Clinical practice recommendations 2003.Diabetes Care,2003,26:94～98. 被引量：1
2Albate N. Obesity and cardiovascular disease pathogenetic role of the metabolic syndrome and therapeutic implication [ J ]. J Diabetes Complications, 2000,14 ( 4 ) : 154 -174. 被引量：1
3Colhoun HM, Lee ET, Bennett PH, et al. Risk factors for renal failure;the WHO multinational study of vascular disease in diabetes [ J ]. Diabetologia ,2001,44 ( 2 ) :46-53. 被引量：1
5Packham DK,Ivory SE,Reutens AT,et al.Proteinuria in type2dia betic patients with renal impairment:the changing face of diabetic nephropathy[J].Nephron Clin Pract,2011,118(4):c331-338. 被引量：1
6Hillege HL,Janssen WM,Bak AA,et al.Microalbuminuria is com-mon,also in a nondiabetic,nonhypertensive population,and an inde-pendent indicator of cardiovascular risk factors and cardiovascular morbidity[J].J Intern Med,2001,249(6):519-526. 被引量：1
8Liu ZH,Liu H,Peng A,et al.Amylin:a new component in the devel opment of renal lesions in patients with type2diabetes mellitus[J].J Am Soc Nephrol,2001,12(12):150A. 被引量：1
